Condition: High Grade Glioma
Intervention: Other: 3T MRI
Sponsor: University of Cincinnati
Recruiting - verified August 2010
Feeds
4318 items (4318 unread) in 87 feeds
Acinar Cell Carcinoma
(24 unread)
Acinic Cell Carcinoma
(33 unread)
Adenoid Cystic Carcinoma
(83 unread)
Adrenal Gland Cancer
(305 unread)
Ampulla Of Vater
(23 unread)
Anal Cancer
(212 unread)
Angiosarcoma
(79 unread)
Appendix Cancer
(66 unread)
Bile Duct Cancer
(332 unread)
Brain and CNS
(1194 unread)
Carcinoid
(124 unread)
Endocrine/Neuroendocrine
(500 unread)
Gall Bladder Cancer
(89 unread)
General
(4 unread)
Hemangioendothelioma
(38 unread)
HemeOnc
(78 unread)
Hepatoblastoma
(46 unread)
Pancreas
(76 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(35 unread)
Rhabdomyosarcoma
(175 unread)
Sarcoma
(313 unread)
Twitter Pals
(468 unread)
Trial - Brain Tumor (100 unread)
-
Radiation Planning Study for High Grade Brain Tumors
Posted: August 25th, 2010, 9:00am CDT
-
R04929097 and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
Posted: August 25th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: bevacizumab; Drug: gamma-secretase inhibitor RO4929097
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified August 2010 -
Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Posted: August 25th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: vorinostat; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified August 2010 -
A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Posted: August 23rd, 2010, 9:00am CDT
Conditions: Juvenile Pilcytic Astrocytoma (JPA); Pleomorphic JPA; Diffuse Astrocytoma (Fibrillary, Gemistocytic, Giant Cell, or Pleomorphic Xanthoastrocytoma); Low Grade Oligoastrocytoma; Low Grade Oligodendroglioma; Low Grade Glioma NOS
Intervention: Drug: Poly ICLC
Sponsors: Emory University; University of California, San Diego
Recruiting - verified August 2010 -
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Posted: August 19th, 2010, 9:00am CDT
Conditions: Glioblastoma Multiforme; Gliosarcoma; Grade IV Malignant Glioma
Intervention: Drug: Gliadel (camustine), Radiation, Avastin (bevacizumab), Temodar (temozolomide)
Sponsors: Duke University; Genentech; Eisai Inc.
Not yet recruiting - verified August 2010 -
Brain Activity and Smoking Cessation
Posted: August 19th, 2010, 9:00am CDT
Condition: Nicotine Dependence
Intervention: Behavioral: Smoking Cessation Counseling
Sponsors: University of Pennsylvania; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Posted: August 16th, 2010, 9:00am CDT
Condition: Healthy
Intervention: Drug: Fluvestrant
Sponsors: Mayo Clinic; National Institutes of Health (NIH); AstraZeneca
Recruiting - verified August 2010 -
A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
Posted: August 14th, 2010, 9:00am CDT
Conditions: Brain Stem Neoplasms; Glioma; Pinealoma
Interventions: Drug: IMC-A12; Drug: Temsirolimus
Sponsor: National Cancer Institute (NCI)
Recruiting - verified July 2010 -
Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment
Posted: August 11th, 2010, 9:00am CDT
Conditions: Brain Tumor; Central Nervous System Neoplasms
Intervention:
Sponsor: Massachusetts General Hospital
Active, not recruiting - verified August 2010 -
Trial Of Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (TEMODAR) For Treatment Of Newly Diagnosed Glioblastoma Multiforme And Anaplastic Astrocytoma
Posted: August 10th, 2010, 9:00am CDT
Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma
Intervention: Drug: Super-Selective Intraarterial Intracranial Infusion of Temozolomide
Sponsor: Weill Medical College of Cornell University
Recruiting - verified August 2010 -
Cognitive Benefits of Aerobic Exercise Across the Age Span
Posted: August 10th, 2010, 9:00am CDT
Condition: Cognitive Function
Interventions: Behavioral: aerobic training; Behavioral: stretching/toning
Sponsor: Columbia University
Not yet recruiting - verified August 2010 -
Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer
Posted: August 5th, 2010, 9:00am CDT
Condition: Lung Cancer
Interventions: Other: questionnaire administration; Procedure: quality-of-life assessment; Radiation: 3-dimensional conformal radiation therapy; Radiation: palliative radiation therapy; Radiation: whole-brain radiation therapy
Sponsor: All Ireland Cooperative Oncology Research Group
Recruiting - verified August 2010 -
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
Posted: July 29th, 2010, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Testicular Germ Cell Tumor
Interventions: Biological: filgrastim; Biological: pegfilgrastim; Drug: carboplatin; Drug: cisplatin; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Other: high-dose chemotherapy with autologous stem cell rescue; Other: laboratory biomarker analysis; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Not yet recruiting - verified July 2010 -
Genetically-modified Neural Stem Cells (NSCs) and 5-Fluorocytosine in Treating Patients Undergoing Surgery For Recurrent High Grade Gliomas
Posted: July 28th, 2010, 9:00am CDT
Conditions: Adult Anaplastic Astrocytoma; Recurrent Grade III Glioma; Recurrent Grade IV Glioma; Adult Anaplastic Oligodendroglioma; Adult Brain Tumor; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Recurrent Adult Brain Tumor; Adult Anaplastic Oligoastrocytoma; Recurrent High Grade Glioma
Interventions: Drug: flucytosine; Other: polymerase chain reaction; Other: immunohistochemistry staining method; Biological: gene therapy; Other: pharmacological study; Other: 3-Tesla magnetic resonance imaging; Other: laboratory biomarker analysis; Procedure: therapeutic conventional surgery; Biological: E. coli CD-expressing genetically modified neural stem cells
Sponsor: City of Hope Medical Center
Recruiting - verified August 2010 -
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Posted: July 28th, 2010, 9:00am CDT
Conditions: Estrogen Receptor Negative (ER-Negative) Breast Cancer; Progesterone Receptor Negative (PR-Negative) Breast Cancer; Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer; Brain Metastases
Intervention: Drug: INIPARIB + irinotecan
Sponsors: BiPar Sciences; UNC Lineberger Comprehensive Cancer Center
Recruiting - verified July 2010 -
Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer
Posted: July 28th, 2010, 9:00am CDT
Condition: Head and Neck Cancer
Intervention: Radiation: Boron Neutron Capture Therapy
Sponsors: Taipei Veterans General Hospital,Taiwan; National Tsing Hua University,Taiwan
Recruiting - verified April 2010 -
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
Posted: July 27th, 2010, 9:00am CDT
Conditions: Brain Tumor; Glioblastoma; Medulloblastoma; Ependymoma
Interventions: Biological: Dendritic Cells; Drug: Imiquimod
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified July 2010 -
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Posted: July 26th, 2010, 9:00am CDT
Conditions: Palliative Care; Communication
Intervention:
Sponsors: Barnes-Jewish Hospital Foundation; National Institute of Nursing Research (NINR)
Recruiting - verified July 2010 -
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
Posted: July 23rd, 2010, 9:00am CDT
Conditions: Breast Neoplasms; Survival Analysis; Antineoplastic Agents; Therapeutic Uses
Intervention: Drug: tamoxifen
Sponsors: Yonsei University; Inje University
Completed - verified October 2009 -
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
Posted: July 22nd, 2010, 9:00am CDT
Conditions: Metastases; Cancer
Interventions: Other: surgery; Radiation: radiosurgery
Sponsor: Barretos Cancer Hospital
Active, not recruiting - verified July 2010 -
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis
Posted: July 22nd, 2010, 9:00am CDT
Conditions: Cancer; Metastasis
Intervention: Radiation: hypofractionated stereotactic radiotherapy
Sponsor: Barretos Cancer Hospital
Recruiting - verified July 2010 -
Vitamin D for Treatment of Glioblastoma Multiforme
Posted: July 18th, 2010, 9:00am CDT
Condition: Glioblastoma Multiforme
Interventions: Other: Surgery; Radiation: Radiotherapy to tumour bed and/or residual tumour; Drug: Temozolomide; Drug: Vitamin D3
Sponsor: Soroka University Medical Center
Not yet recruiting - verified August 2010 -
Temozolomide With or Without Bevacizumab in Treating Patients With Recurrent Glioma
Posted: July 15th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: bevacizumab; Drug: temozolomide; Other: laboratory biomarker analysis
Sponsor: European Organization for Research and Treatment of Cancer
Not yet recruiting - verified July 2010 -
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Posted: July 14th, 2010, 9:00am CDT
Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Ependymoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Myxopapillary Ependymoma; Adult Oligodendroglioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Subependymal Giant Cell Astrocytoma; Adult Subependymoma
Interventions: Procedure: biopsy; Procedure: computed tomography; Procedure: therapeutic conventional surgery; Radiation: radiation therapy treatment planning/simulation; Radiation: radiation therapy; Procedure: magnetic resonance imaging; Procedure: positron emission tomography; Drug: fluorine F 18 fluorodopa
Sponsor: Mayo Clinic
Not yet recruiting - verified July 2010 -
Cyberknife Radiosurgery and Quality of Life
Posted: July 14th, 2010, 9:00am CDT
Conditions: Bone Cancer; Brain (Nervous System) Cancers; Brain (Nervous System) Cancers Metastatic Spine Cancer
Intervention: Procedure: pain rating survey
Sponsor: Stanford University
Not yet recruiting - verified July 2010 -
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Posted: July 14th, 2010, 9:00am CDT
Conditions: Neuroendocrine Tumors; Brain (Nervous System) Cancers; Colon/Rectal Cancer; Colon/Rectal Cancer Colon Cancer; Hepatobiliary Cancers; Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma); Hepatobiliary Cancers Liver
Intervention: Procedure: CT perfusion
Sponsors: Stanford University; Siemens Healthcare Sector; GE Healthcare
Not yet recruiting - verified July 2010 -
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Posted: July 7th, 2010, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Lymphoma; Sarcoma
Interventions: Drug: VEGF inhibitor PTC299; Other: enzyme-linked immunosorbent assay; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI); PTC Therapeutics Incorporated
Not yet recruiting - verified July 2010 -
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Posted: July 7th, 2010, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Breast Cancer; Colorectal Cancer; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: capecitabine; Drug: gamma-secretase inhibitor RO4929097; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Other: pharmacological study
Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI)
Recruiting - verified July 2010 -
A Study of a Replication Competent Retrovirus Administered to Subjects With Recurrent Glioblastoma (GBM)
Posted: July 1st, 2010, 9:00am CDT
Condition: Recurrent Glioblastoma
Interventions: Biological: Toca 511; Drug: 5-FC
Sponsor: Tocagen Inc.
Recruiting - verified July 2010 -
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Posted: June 25th, 2010, 9:00am CDT
Conditions: Adult Brain Tumor; Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Meningioma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Choroid Plexus Tumor; Adult Craniopharyngioma; Adult Diffuse Astrocytoma; Adult Ependymoblastoma; Adult Ependymoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Grade I Meningioma; Adult Grade II Meningioma; Adult Medulloblastoma; Adult Melanocytic Lesion; Adult Meningeal Hemangiopericytoma; Adult Mixed Glioma; Adult Myxopapillary Ependymoma; Adult Oligodendroglioma; Adult Papillary Meningioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Pineoblastoma; Adult Pineocytoma; Adult Subependymal Giant Cell Astrocytoma; Adult Subependymoma; Adult Supratentorial Primitive Neuroectodermal Tumor (PNET); Recurrent Adult Brain Tumor
Interventions: Drug: pioglitazone hydrochloride; Other: laboratory biomarker analysis; Radiation: external beam radiation therapy; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy; Procedure: management of therapy complications
Sponsor: Wake Forest University
Terminated - verified December 2009 -
Effects of Steroid Tapering on Functional Capacity and Neurocognition
Posted: June 25th, 2010, 9:00am CDT
Condition: Glioblastoma Multiforme
Interventions: Drug: Dexamethasone acetate; Drug: Dexamethasone
Sponsor: Duke University
Not yet recruiting - verified July 2010 -
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea
Posted: June 24th, 2010, 9:00am CDT
Condition: Japanese Encephalitis
Intervention: Biological: JE vaccine
Sponsors: Boryung Pharmaceutical Co., Ltd; Seoul National University Hospital; Gachon University Gil Medical Center; Inha University Hospital; Inje University; Korea Cancer Center Hospital; Samsung Medical Center; The Catholic University of Korea; Ewha Womans University
Not yet recruiting - verified June 2010 -
Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)
Posted: June 23rd, 2010, 9:00am CDT
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Prophylactic cranial irradiation; Drug: Erlotinib /Gefitinib
Sponsor: Zhejiang Cancer Hospital
Recruiting - verified July 2010 -
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
Posted: June 23rd, 2010, 9:00am CDT
Conditions: Heart Failure; Liver Cirrhosis; Ascites; Carcinomatosis
Intervention: Procedure: BNP, SAAG, ascites total protein, echocardiography
Sponsors: University of Sao Paulo; University of Sao Paulo General Hospital
Recruiting - verified June 2010 -
Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
Posted: June 21st, 2010, 9:00am CDT
Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Recurrent Adult Brain Tumor
Interventions: Drug: aminolevulinic acid; Other: laboratory biomarker analysis; Procedure: therapeutic conventional surgery
Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting - verified July 2010 -
Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma
Posted: June 15th, 2010, 9:00am CDT
Condition: Recurrent Malignant Glioma
Intervention: Drug: Bevacizumab / Irinotecan
Sponsors: Medical University Innsbruck; Roche, Austria
Recruiting - verified June 2010 -
The Role of GLP-1 in Satiety Perception in Humans
Posted: June 15th, 2010, 9:00am CDT
Conditions: Appetite Regulation; Obesity
Interventions: Drug: Exendin-(9-39) Acetate; Drug: Saline 0.9%
Sponsors: University of Washington; Fred Hutchinson Cancer Research Center
Not yet recruiting - verified June 2010 -
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
Posted: June 14th, 2010, 9:00am CDT
Condition: Glioblastoma
Interventions: Drug: Temozolomide and lomustine; Drug: Temozolomide
Sponsor: University Hospital, Bonn
Not yet recruiting - verified April 2010 -
Cellular Immunotherapy Study for Brain Cancer
Posted: June 11th, 2010, 9:00am CDT
Conditions: Gliomas; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Glioma; Glioblastoma Multiforme
Intervention: Drug: alloCTL
Sponsors: University of California, Los Angeles; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified June 2010 -
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Posted: May 7th, 2010, 9:00am CDT
Conditions: Acoustic Schwannoma; Adult Anaplastic Meningioma; Adult Ependymoma; Adult Grade I Meningioma; Adult Grade II Meningioma; Adult Meningeal Hemangiopericytoma; Adult Papillary Meningioma; Neurofibromatosis Type 1; Neurofibromatosis Type 2; Recurrent Adult Brain Tumor
Intervention: Biological: bevacizumab
Sponsor: Northwestern University
Not yet recruiting - verified May 2010 -
PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Posted: May 7th, 2010, 9:00am CDT
Conditions: Glioblastoma; Brain (Nervous System) Cancers; Brain (Nervous System) Cancers Glioblastoma
Interventions: Drug: Temozolomide; Procedure: Hypofractionated Radiotherapy
Sponsor: Stanford University
Recruiting - verified June 2010 -
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Posted: May 6th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: gamma-secretase inhibitor RO4929097; Drug: temozolomide; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Not yet recruiting - verified May 2010 -
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
Posted: May 4th, 2010, 9:00am CDT
Conditions: Pediatric Cancer; Leukemia; Sarcoma; Brain Tumors
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2010 -
A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
Posted: May 4th, 2010, 9:00am CDT
Conditions: Ependymoma; Brainstem Glioma; Astrocytoma; Glioblastoma Multiforme; PNET
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2010 -
Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
Posted: May 3rd, 2010, 9:00am CDT
Condition: Glioma
Intervention: Drug: 5-Aminolevuline Acid
Sponsor: University of California, San Francisco
Recruiting - verified August 2010 -
High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
Posted: April 30th, 2010, 9:00am CDT
Conditions: Non-Hodgkin's Lymphoma; CNS Lymphoma
Intervention: Procedure: High-dose chemotherapy with autologous stem cell transplant
Sponsors: Massachusetts General Hospital; Genentech; Otsuka America Pharmaceutical; Dana-Farber Cancer Institute
Recruiting - verified August 2010 -
AMG 102 and Avastin for Recurrent Malignant Glioma
Posted: April 28th, 2010, 9:00am CDT
Conditions: Grade IV Malignant Glioma; Glioblastoma Multiforme; Gliosarcoma
Intervention: Drug: AMG 102 plus Avastin (bevacizumab)
Sponsors: Duke University; Amgen
Recruiting - verified August 2010 -
TPI 287 in Patients With Recurrent Glioblastoma Multiforme
Posted: April 27th, 2010, 9:00am CDT
Condition: Brain Cancer
Intervention: Drug: TPI 287
Sponsors: M.D. Anderson Cancer Center; Archer Biosciences, Inc.
Recruiting - verified August 2010 -
Vorinostat, Erlotinib and Carboplatin for Recurrent Glioblastoma Multiforme
Posted: April 22nd, 2010, 9:00am CDT
Conditions: Brain Cancer; Glioblastoma Multiforme
Interventions: Drug: Vorinostat; Drug: Erlotinib; Drug: Carboplatin
Sponsors: M.D. Anderson Cancer Center; Merck
Not yet recruiting - verified August 2010 -
A Study of Capecitabine [Xeloda] and Concomitant Radiation Therapy in Children and Adolescent Patients With Newly Diagnosed Brainstem Glioma
Posted: April 15th, 2010, 9:00am CDT
Condition: Glioma
Intervention: Drug: capecitabine [Xeloda]
Sponsors: Hoffmann-La Roche; Pediatric Brain Tumor Consortium (PBTC)
Recruiting - verified August 2010 -
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
Posted: April 15th, 2010, 9:00am CDT
Condition: Glioblastoma
Intervention: Other: Radiologic exams
Sponsors: Massachusetts General Hospital; Dana-Farber Cancer Institute
Not yet recruiting - verified June 2010 -
Study of Administration of CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
Posted: April 13th, 2010, 9:00am CDT
Condition: Brain Cancer
Intervention: Drug: HER.CAR CMV-specific CTL
Sponsors: Baylor College of Medicine; The Methodist Hospital System; Center for Cell and Gene Therapy, Baylor College of Medicine
Not yet recruiting - verified July 2010 -
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Posted: April 13th, 2010, 9:00am CDT
Conditions: Recurrent Adult Brain Tumor; Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Oligodendroglioma
Interventions: Drug: erlotinib hydrochloride; Drug: isotretinoin; Other: laboratory biomarker analysis; Genetic: protein expression analysis
Sponsor: Wake Forest University
Recruiting - verified June 2010 -
Supplementation of Lycopene in Carotid Atheroma
Posted: April 12th, 2010, 9:00am CDT
Condition: Carotid Atherosclerotic Disease
Interventions: Drug: lycopene 25 mg/day; Drug: Placebo
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge Theranostics Ltd.
Not yet recruiting - verified June 2010 -
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
Posted: April 7th, 2010, 9:00am CDT
Conditions: ALL, Childhood; Leukemia, Lymphoblastic; Leukemia, Lymphoblastic, Acute; Leukemia, Lymphoblastic, Acute, L1; Leukemia, Lymphoblastic, Acute, L2; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive; Leukemia, Lymphocytic, Acute; Leukemia, Lymphocytic, Acute, L1; Leukemia, Lymphocytic, Acute, L2; Lymphoblastic Leukemia; Lymphoblastic Leukemia, Acute; Lymphoblastic Leukemia, Acute, Childhood; Lymphoblastic Leukemia, Acute, L1; Lymphoblastic Leukemia, Acute, L2; Lymphoblastic Lymphoma; Lymphocytic Leukemia, Acute; Lymphocytic Leukemia, L1; Lymphocytic Leukemia, L2; Brain Tumors; Cancer of the Brain; Cancer of Brain; Malignant Primary Brain Tumors; Brain Neoplasms, Malignant
Interventions: Drug: Methylphenidate; Drug: Placebo
Sponsors: Masonic Cancer Center, University of Minnesota; Children's Cancer Research Fund
Recruiting - verified May 2010 -
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Posted: March 30th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: vincristine sulfate; Other: clinical observation; Radiation: 3-dimensional conformal radiation therapy
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Posted: March 26th, 2010, 9:00am CDT
Conditions: Brain Tumor; Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Oligodendroglioma; Brain Stem Glioma; Giant Cell Glioblastoma; Glioblastoma; Gliosarcoma; Mixed Glioma
Interventions: Drug: ritonavir; Drug: lopinavir
Sponsor: Case Comprehensive Cancer Center
Active, not recruiting - verified June 2010 -
Studies of Autistic Patients: Gene Networks and Clinical Subtypes
Posted: March 23rd, 2010, 9:00am CDT
Conditions: Autism; Tuberous Sclerosis
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010 -
MEK Inhibitor AZD6244 in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Posted: March 17th, 2010, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: MEK inhibitor AZD6244; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2010 -
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
Posted: March 16th, 2010, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: dexamethasone; Drug: gamma-secretase inhibitor RO4929097; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Therapeutic Tumor-Selective Donor Lymphocytes and Aldesleukin in Treating Patients With Malignant Glioma
Posted: March 5th, 2010, 9:00am CST
Conditions: Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Meningioma; Anaplastic Oligodendroglioma; Brain Stem Glioma; Ependymoblastoma; Giant Cell Glioblastoma; Glioblastoma; Gliosarcoma; Grade III Meningioma; Meningeal Hemangiopericytoma; Mixed Glioma; Pineal Gland Astrocytoma; Brain Tumor
Interventions: Biological: therapeutic allogeneic lymphocytes; Biological: aldesleukin; Other: laboratory biomarker analysis; Procedure: positron emission tomography
Sponsor: City of Hope Medical Center
Recruiting - verified May 2010 -
Phase I Study To Test The Safety of TVAX Immunotherapy As A Treatment For Recurrent Grade III/IV Gliomas
Posted: March 3rd, 2010, 9:00am CST
Conditions: Glioma; High Grade Astrocytoma; Glioblastoma Multiforme
Intervention: Biological: Cancer vaccine plus immune adjuvant, plus activated white blood cells
Sponsor: TVAX Biomedical
Active, not recruiting - verified August 2010 -
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
Posted: February 25th, 2010, 9:00am CST
Conditions: Brain and Central Nervous System Tumors; Malignant Paraganglioma
Interventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Pharmacokinetic and -Dynamic of Propofol During Awake Craniotomy
Posted: February 22nd, 2010, 9:00am CST
Condition: Brain Tumor
Intervention:
Sponsor: University Hospital, Bonn
Recruiting - verified May 2010 -
APG101 in Glioblastoma
Posted: February 18th, 2010, 9:00am CST
Condition: Glioblastoma Multiforme
Interventions: Drug: APG101; Procedure: Blood drawing
Sponsor: Apogenix GmbH
Recruiting - verified August 2010 -
Study of Multiple Doses and Regimens of XL184 in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Posted: February 12th, 2010, 9:00am CST
Condition: Astrocytic Tumors
Intervention: Drug: XL184
Sponsor: Exelixis
Recruiting - verified August 2010 -
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
Posted: February 10th, 2010, 9:00am CST
Conditions: Brain Cancer; Glioblastoma
Interventions: Drug: Standard Dose Bevacizumab; Drug: Low Dose Bevacizumab; Drug: Lomustine
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified August 2010 -
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Posted: February 3rd, 2010, 9:00am CST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cediranib maleate; Drug: temozolomide; Other: placebo; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Influence of Intracranial Lesions on Bispectral Index
Posted: February 1st, 2010, 9:00am CST
Condition: Supratentorial Brain Tumor
Interventions: Device: BIS values at return of consciousness in patients + predicted and measured propofol plasma concentrations; Device: BIS values at return of consciousness in patients + predicted and measured propofol plasma concentrations
Sponsor: University Medical Centre Groningen
Recruiting - verified November 2009 -
PI EGFRvIII Peptide Vaccination After Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas
Posted: January 27th, 2010, 9:00am CST
Conditions: Brain Cancer; Brain (Nervous System) Cancers; Brain (Nervous System) Cancers Glioblastoma; Brain (Nervous System) Cancers Meningioma; Brain (Nervous System) Cancers Oligodendroglioma; Brain (Nervous System) Cancers Astrocytoma; Brain (Nervous System) Cancers Metastatic Spine Cancer; Brain (Nervous System) Cancers Metastatic Brain Tumors
Intervention: Biological: EGFRvIII
Sponsors: Stanford University; National Institutes of Health (NIH)
Not yet recruiting - verified June 2010 -
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Posted: January 22nd, 2010, 9:00am CST
Condition: Lung Cancer
Interventions: Radiation: prophylactic cranial irradiation; Radiation: selective external radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression
Posted: January 15th, 2010, 9:00am CST
Condition: Breast Cancer
Intervention: Drug: capecitabine [Xeloda]
Sponsor: Hoffmann-La Roche
Recruiting - verified August 2010 -
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Posted: January 12th, 2010, 9:00am CST
Conditions: Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cilengitide; Other: clinical observation
Sponsors: University of Chicago; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Posted: January 6th, 2010, 9:00am CST
Conditions: Glioblastoma Multiforme; Glioma; Astrocytoma; Brain Tumor
Intervention: Drug: Intrathecal liposomal Ara-C + Temozolomide
Sponsor: Medical University of South Carolina
Recruiting - verified July 2010 -
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Posted: January 5th, 2010, 9:00am CST
Conditions: Mucopolysaccharidosis; Hurler Syndrome; Hunter Syndrome; Maroteaux-Lamy Syndrome; Sly Syndrome; Alpha Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Adrenoleukodystrophy; Globoid Cell Leukodystrophy; Krabbe Disease; Sphingolipidoses; Peroxisomal Disorders
Interventions: Drug: Campath-1H; Drug: Cyclophosphamide; Drug: Busulfan; Procedure: Allogeneic stem cell transplantation
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified July 2010 -
Aspirin in Reducing Events in the Elderly
Posted: December 21st, 2009, 9:00am CST
Conditions: Functional Disability; Dementia; Heart Disease; Stroke; Cancer; Bleeding
Interventions: Drug: 100 mg enteric-coated aspirin; Drug: Placebo
Sponsors: Minneapolis Medical Research Foundation; National Health and Medical Research Council, Australia; Bayer; Monash University; Berman Center for Outcomes and Clinical Research
Recruiting - verified January 2010 -
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
Posted: December 19th, 2009, 9:00am CST
Conditions: Cannabis; Dependence; Cannabis Abuse; Pharmacokinetics; fMRI
Interventions: Drug: Sativex(Registered Trademark); Drug: THC
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2010 -
Inflammatory Cytokines Associated With Perinatal Brain Injury
Posted: December 17th, 2009, 9:00am CST
Conditions: Infant, Newborn; Infant, Low Birth Weight; Infant, Small for Gestational Age; Infant, Premature; Cerebral Palsy
Intervention:
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Centers for Disease Control and Prevention
Completed - verified April 2010 -
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Posted: December 13th, 2009, 9:00am CST
Conditions: Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Fatigue
Interventions: Drug: armodafinil; Other: placebo
Sponsors: Wake Forest University; National Cancer Institute (NCI)
Not yet recruiting - verified August 2010 -
ABT-888 and Temozolomide in Treating Patients With Recurrent Glioblastoma
Posted: December 3rd, 2009, 9:00am CST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Drug: veliparib
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
Posted: December 2nd, 2009, 9:00am CST
Conditions: Adult Brain Tumor; Adult Brain Stem Glioma; Adult Diffuse Astrocytoma; Adult Ependymoma; Adult Grade II Meningioma; Adult Melanocytic Lesion; Adult Meningeal Hemangiopericytoma; Adult Mixed Glioma; Adult Oligodendroglioma; Adult Pineal Gland Astrocytoma; Adult Pineocytoma; Recurrent Adult Brain Tumor
Interventions: Radiation: proton beam radiation therapy; Procedure: quality-of-life assessment; Other: questionnaire administration
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified June 2010 -
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Posted: November 24th, 2009, 9:00am CST
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Drug: temsirolimus; Genetic: DNA methylation analysis; Other: laboratory biomarker analysis; Procedure: adjuvant therapy; Radiation: external beam radiation therapy
Sponsor: European Organization for Research and Treatment of Cancer
Recruiting - verified April 2010 -
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors
Posted: November 13th, 2009, 9:00am CST
Conditions: Neurocognitive Impairment; Acute Lymphoblastic Leukemia
Intervention: Other: Neurocognitive and behavioral evaluation
Sponsors: St. Jude Children's Research Hospital; National Cancer Institute (NCI); National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 -
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
Posted: November 11th, 2009, 9:00am CST
Condition: Brain Cancer
Intervention: Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
Sponsors: Memorial Sloan-Kettering Cancer Center; Children's Healthcare of Atlanta; Dana-Farber Cancer Institute; M.D. Anderson Cancer Center; Phoenix Children's Hospital; Sidney Kimmel Comprehensive Cancer Center; Alberta Children's Hospital; University of Colorado, Denver; University of Florida; Vanderbilt University; Emory University
Recruiting - verified May 2010 -
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Posted: November 11th, 2009, 9:00am CST
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: bevacizumab; Drug: temozolomide; Genetic: gene expression analysis; Other: laboratory biomarker analysis; Procedure: adjuvant therapy; Radiation: external beam radiation therapy
Sponsors: University of California, Los Angeles; National Cancer Institute (NCI)
Active, not recruiting - verified June 2010 -
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Posted: October 29th, 2009, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Genetic: DNA ploidy analysis; Genetic: fluorescence in situ hybridization; Genetic: microsatellite instability analysis; Genetic: mutation analysis; Genetic: polymerase chain reaction; Other: diagnostic laboratory biomarker analysis; Other: flow cytometry; Other: immunohistochemistry staining method
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified July 2010 -
Shanghai Parkinson's Study
Posted: October 20th, 2009, 9:00am CDT
Condition: Parkinson's Disease
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified June 2010 -
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Posted: October 17th, 2009, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bortezomib; Drug: temozolomide; Other: laboratory biomarker analysis; Procedure: adjuvant therapy; Radiation: external beam radiation therapy
Sponsors: University of California, Los Angeles; National Cancer Institute (NCI)
Not yet recruiting - verified June 2010 -
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Posted: October 10th, 2009, 9:00am CDT
Conditions: Glioblastoma Multiforme; Gliosarcoma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Mixed Oligoastrocytoma
Interventions: Drug: ZD6474; Drug: Carboplatin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified June 2010 -
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
Posted: October 10th, 2009, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib; Drug: vorinostat; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Suspended - verified August 2010 -
High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Posted: October 7th, 2009, 9:00am CDT
Conditions: Stage IV Breast Cancer; Central Nervous System Involvement/Metastases; Leptomeningeal Metastases; Recurrent Breast Cancer; Tumors Metastatic to Brain
Interventions: Drug: methotrexate; Drug: liposomal cytarabine; Other: quality-of-life assessment; Other: questionnaire administration
Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting - verified August 2010 -
Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
Posted: October 6th, 2009, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: bortezomib; Drug: temozolomide
Sponsors: Northwestern University; Millennium Pharmaceuticals, Inc.
Recruiting - verified May 2010 -
Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
Posted: September 24th, 2009, 9:00am CDT
Condition: Glioblastoma Multiforme
Interventions: Drug: BCNU Wafer; Drug: Irinotecan; Drug: Bevacizumab
Sponsors: University of Cincinnati; Eisai Inc.
Terminated - verified August 2010 -
Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors
Posted: September 23rd, 2009, 9:00am CDT
Conditions: Central Nervous System Embryonal Tumor; Germ Cell Tumors
Interventions: Drug: Melphalan; Drug: Carboplatin; Drug: Sodium thiosulfate; Drug: Filgrastim; Drug: Pegfilgrastim
Sponsor: OHSU Knight Cancer Institute
Recruiting - verified May 2010 -
Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue
Posted: September 22nd, 2009, 9:00am CDT
Conditions: Idiopathic Chronic Fatigue; Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
Intervention:
Sponsors: University of Utah; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified August 2010 -
Stereotactic Radiosurgery With Sunitinib for Brain Metastases
Posted: September 21st, 2009, 9:00am CDT
Condition: Brain Metastases
Intervention: Drug: Sunitinib
Sponsor: University Health Network, Toronto
Recruiting - verified August 2010 -
GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Posted: September 18th, 2009, 9:00am CDT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Hedgehog antagonist GDC-0449; Procedure: therapeutic conventional surgery
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified January 2010 -
Image-Guided Stereotactic Biopsy of High Grade Gliomas
Posted: September 17th, 2009, 9:00am CDT
Conditions: Brain Cancer; Glioma
Intervention: Procedure: 18F-FLT PET Scan
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Recruiting - verified May 2010 -
Imaging Vascular Properties of Pediatric Brain Tumors Using Ferumoxytol and Gadolinium in a Single Imaging Session
Posted: September 16th, 2009, 9:00am CDT
Condition: Brain Neoplasms
Intervention: Drug: ferumoxytol
Sponsors: OHSU Knight Cancer Institute; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - verified May 2010 -
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Posted: September 16th, 2009, 9:00am CDT
Conditions: Brain and Central Nervous System Tumors; Neurotoxicity
Interventions: Drug: temozolomide; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010